Heron Therapeutics
HRTX
#7836
Rank
S$0.35 B
Marketcap
$2.31
Share price
0.58%
Change (1 day)
-37.47%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.60

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.56. In 2022 the company made an earnings per share (EPS) of -$2.31 an increase over its 2021 EPS that were of -$3.01.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.60-30.55%
2022-$2.31-23.11%
2021-$3.01-10%
2020-$3.34-0%
2019-$3.341.21%
2018-$3.30-32.7%
2017-$4.90-19.34%
2016-$6.0854.76%
2015-$3.931.73%
2014-$3.86-16.23%
2013-$4.6191.67%
2012-$2.40-31.45%
2011-$3.51-27.06%
2010-$4.81-43.75%
2009-$8.55-57.33%
2008-$20.04-82.92%
2007-$117.2920.61%
2006-$97.25175.76%
2005-$35.27-21.43%
2004-$44.89100%
2003-$22.44-38.24%
2002-$36.34161.54%
2001-$13.89-106.46%
2000$214.942051.55%
1999$9.99839.73%
1998$1.06-105.48%
1997-$19.41-88.16%
1996-$163.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.74-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.19-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.18 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.10-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.20 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA